Please assess the completion status of the following clinical trial:

Trial Title: Mecillinam for Treatment of Genital Chlamydia Infection

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Proficient in oral and written Norwegian~* Positive NAAT in first void urine for Chlamydia trachomatis~* Negative NAAT in first void urine for Mycoplasma genitalium~* Heterosexual male~* Asymptomatic~Exclusion Criteria:~* Known allergies for mecillinam, penicillin or cephalosporines~* Metabolic anomalies of aciduric type~* Apparent underweight~* Use of mecillinam within the last two months~* Under treatment with Valproat, other anti-infective drugs, immuno-modulating medication~* In the opinion of investigator,obvious reasons why patient will fails to adhere to treatment and follow-up protocol

- Gender: MALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Pivmecillinamhydrochlorid (Type: EXPERIMENTAL): Selexid 400 mg x 3 , 7 days

Based on this trial design, predict the completion outcome and termination type (if applicable).